Matrix Capital Management Company’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $35.8M | Sell |
|
|||||
|
2024
Q2 | $38M | Hold |
|
|||||
|
2024
Q1 | $61.6M | Hold |
|
|||||
|
2023
Q4 | $30.9M | Hold |
|
|||||
|
2023
Q3 | $30.4M | Hold |
|
|||||
|
2023
Q2 | $36.1M | Hold |
|
|||||
|
2023
Q1 | $42.5M | Hold |
|
|||||
|
2022
Q4 | $56.9M | Hold |
|
|||||
|
2022
Q3 | $41.9M | Hold |
|
|||||
|
2022
Q2 | $66.3M | Hold |
|
|||||
|
2022
Q1 | $80.3M | Hold |
|
|||||
|
2021
Q4 | $146M | Hold |
|
|||||
|
2021
Q3 | $201M | Hold |
|
|||||
|
2021
Q2 | $166M | Hold |
|
|||||
|
2021
Q1 | $207M | Hold |
|
|||||
|
2020
Q4 | $210M | Hold |
|
|||||
|
2020
Q3 | $311M | Hold |
|
|||||
|
2020
Q2 | $390M | Buy |
|
|||||
|
2020
Q1 | $93.6M | Buy |
|
|||||
|
2019
Q4 | $33.6M | Hold |
|
|||||
|
2019
Q3 | $42.3M | Hold |
|
|||||
|
2019
Q2 | $113M | Hold |
|
|||||
|
2019
Q1 | $120M | Buy |
|
|||||
|
2018
Q4 | $156M | Buy |
|
|||||
|
2018
Q3 | $276M | Buy |
|
|||||
|
2018
Q2 | $167M | Buy |
|
|||||
|
2018
Q1 | $156M | Buy |
|
|||||
|
2017
Q4 | $81.6M | Buy |
|
|||||
|
2017
Q3 | $98.6M | Buy |
|
|||||
|
2017
Q2 | $39M | Buy |
|